Member Exclusive NEWS ROUND-UP

Cell therapy weekly: job losses at Lonza and positive results in stage IV pancreas cancer

This week: autologous therapies shown to safe and tolerated in pancreatic cancer and type 1 diabetes trials, and new biopharma will develop candidate from MD Anderson Cancer Center.

Go to the profile of RegMedNet
Mar 08, 2018
0
0

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.

Register

No comments yet.